FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
June 09, 2023 at 10:07 AM EDT
Medicare has promised to broadly cover Leqembi, which costs $26,500 per year, if the FDA grants full approval of the treatment.
